P. Herzen Moscow Oncology Rese
P. Herzen Moscow Oncology Rese
P. Herzen Moscow Oncology Rese, Russia1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION) | Non-small Cell Lung Cancer NSCLC | Active, not recruiting | Phase 2 | 2026-09-11 | NCT03775486 |